Advik Laboratories Share Price History and Returns 2015 to 2024
Advik Laboratories Limited | |||
Price: ₹4.25 | |||
52 Week Low: ₹3.93 52 Week High: ₹4.33 | |||
Market Capital: N/A | |||
-> |
Show Table of Contents
Table of Contents
- 1: Advik Laboratories Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Advik Laboratories Recent Performance
- 3: Advik Laboratories Stock Price Chart From 2015 to 2024
- 4: Advik Laboratories Stock Price History Table From 2015 to 2024
- 5: Analyzing the Impact of Investing in Advik Laboratories
- 5.1: Advik Laboratories Stock Returns In Last 5 Years
- 6: Advik Laboratories Returns vs Bank FD Returns
Advik Laboratories Stock Highlights
As of 23 Dec 2024, Advik Laboratories Stock price is ₹4.25 which is ₹0.08 below 52-week high of ₹4.33 and ₹0.32 above 52-week low of ₹3.93
52-Week High Low
- Advik Laboratories 52-Week High is ₹4.33 occurred on 23 Dec 2024
- Advik Laboratories 52-Week Low is ₹3.93 occurred on 23 Dec 2024
All Time High
- The all-time high or the highest price that Advik Laboratories stocks have ever touched was ₹15.42 and this occurred on 27 Dec 2024.
- The highest closing price at which Advik Laboratories stocks have ever closed was ₹11.93 recorded on 27 Dec 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Advik Laboratories Recent Performance
Over the past 15 trading days, the value of Advik Laboratories's stock has increased by ₹0.41 (+10.68%). On 26 Aug 2024, its one share was worth ₹3.84 and by 23 Dec 2024, the value jumped to ₹4.25. During this period it created a highest high of ₹4.33 and lowest low of ₹3.65.
Click on legend items to show/hide respective price lines
Advik Laboratories Stock Price Chart From 2015 to 2024
Click on legend items to show/hide respective price lines
Advik Laboratories Stock Price History Table From 2015 to 2024
Year | Advik Laboratories | YOY Chg% | ↑High - ↓Low |
---|---|---|---|
2024 | ₹4.25 | 52.3% | ↑ ₹4.33 ↓ ₹2.79 |
2023 | ₹2.79 | 46.0% | ↑ ₹2.79 ↓ ₹1.91 |
2022 | ₹1.91 | 50.3% | ↑ ₹1.91 ↓ ₹1.27 |
2021 | ₹1.27 | 252.7% | ↑ ₹1.27 ↓ ₹0.36 |
2020 | ₹0.36 | -2.8% | ↑ ₹0.37 ↓ ₹0.32 |
2019 | ₹0.37 | -82.5% | ↑ ₹2.11 ↓ ₹0.36 |
2018 | ₹2.11 | -61.2% | ↑ ₹7.37 ↓ ₹2.11 |
2017 | ₹5.43 | -3.8% | ↑ ₹9.02 ↓ ₹3.95 |
2016 | ₹5.64 | -52.8% | ↑ ₹15.42 ↓ ₹4.50 |
2015 | ₹11.93 | - | ↑ ₹15.10 ↓ ₹4.80 |
Analyzing the Impact of Investing in Advik Laboratories
Advik Laboratories Stock price in the year 2015 was ₹11.93. If you had invested ₹10,000 in Advik Laboratories Stock in 2015, in 9 years, your investment would have reduced to ₹3,562 by the end of 2024. This represents a negative return of -64.4% from 2015 to 2024, with a compound annual growth rate (CAGR) of -10.9%.
Advik Laboratories Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹4.33 and lowest was: ₹0.32
- Advik Laboratories Stock price in 2019 was ₹0.37
- By 2024, its stock price rose to ₹4.25
- It gave a positive return of over 1,048.6% with a CAGR of 62.9% over the last 5 years
- If you had invested ₹10,000 in Advik Laboratories in 2019 then in 5 years, your investment would have grown to ₹1.14 Lakh by 2024, which is 11.49 times of your initial investment.
Advik Laboratories Returns vs Bank FD Returns
Investment Type | Initial Amount | Final Value | Total Returns |
---|---|---|---|
Advik Laboratories Shares | ₹10,000 | ₹3,562.44 | -64.4% |
Bank FD (Simple Interest) | ₹10,000 | ₹15,400 | 54.0% |
Bank FD (Compound Interest) | ₹10,000 | ₹16,894.78 | 68.9% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.